Reggie, good on you for sticking to your guns and numbers. For most, this has been a long haul investment. Investor fatigue set in some time ago. In saying that Management knew the Science was solid so took the long hard road to maximise our assets. For those that stuck with NEU (the science, the management, the patients), our time is near.
There is 0% chance (in my opinion) that Management is going to give this company away. Our day is coming and whatever road Management take I believe it will be the best outcome for all stakeholders. This once in a lifetime opportunity (a block buster drug designed in NZ) is at the pointy end.
Most contributors on this thread helped me keep the faith during the tough times. This is the gnarliest financial roller coaster I’ve ever been on. For me from an investment point of view news flow out weighs price. In the next 9 months we have plenty of headlines to come.
Not long now. Hold fast ✊
Pending ROW deal??, page-177
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.63 |
Change
-1.080(6.46%) |
Mkt cap ! $1.997B | |||
| Open | High | Low | Value | Volume |
| $16.61 | $16.65 | $15.54 | $8.354M | 529.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 830 | $15.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.74 | 1484 | 2 |
View Market Depth
| Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |